Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Enjoy your FREE PREVIEW which shows only 2022 data and 25 documents. Contact Patent Forecast for full access.        


Read More News and Insights

Patent Granted for Enantiopure Cannabinoid Purification

Z-ARCHIVE-Cannabis Patent Forecast®

May 14, 2020

Flavor, fragrance, natural nutrition, and cosmetic ingredients solutions company Symrise had a patent (US Pat. No. 10,647,691) published this week for a method of purifying cannabinoids using enantiopure synthesis. An enantiomer is one of two molecules that is a mirror image of the other molecule. Obtaining an enantiopure solution is a daunting task but can ameliorate serious side effects caused by one of the mirror image molecules. 

Take for instance ibuprofen. It contains within it a roughly 50% enantiomer solution. One of the enantiomers has ill effects on the liver and gastrointestinal lining which is a reason why ibuprofen is recommended with food. Seractil and Motrin are both ibuprofen; however, you’ll realize the steep cost difference between them, and that is because Seractil is an enantiopure drug.

A study from the University of Toronto suggests that the same holds true for cannabinoid enantiomers - opening a gateway into therapeutics research left untouched.  

Stay in the loop for cannabis IP and market data updates with a subscription to Magic Number’s Cannabis Patent Forecast®. Patent Forecast® combines a suite of powerful analytical tools to discover trends using market data and patent activity. 

Lago Di Limides, Dolomites, Alpine, Italy, Mountains

Relevant Patent Documents

Patent US10647691  

Read more like this in News This Week!   or   Share this link with your connections!